Member Info for djm1

What are these guys like for banging the drum?

Conrad holds a 76.5% operated interest in the Duyung PSC , with a revised POD approved by the Indonesian regulator seeing contingent resources increased by 458% (relative to the initial POD). The Duyung PSC includes the Mako gas field which contains close to 500 billion cubic feet, of which 297 billion cubic feet is net attributable to the joint venture where Conrad owns 76.5%. The company is currently in discussions with buyers in Singapore and Indonesia regarding gas sales agreements, with two Heads of Agreement already signed with buyers from Singapore.

Conrad already has an approved plan of development and work is currently underway to conclude a gas sales contract with a Singapore gas buyer and Indonesian regulator SKK Migas, which could allow for first gas sales in 2025 transitioning Conrad Asia into a significant cash flow generator.

Coro 15% of 297 Billion Cubic Feet of Gas, 44.5 Billion Cubic Feet, $85million dollars approx.

In line with the Company's previously announced strategic change to focus on larger integrated service contracts, the Company has engaged with several potential clients for the broader service offering, which has been very positively received. In particular, negotiations concerning a significant order for an integrated service contract have progressed but have not materialised in time for the end of this year. While there is the possibility that negotiations could be completed in the near term, the majority of the revenues would be recognisable in the financial year commencing 1 April 2023.

March Trading Statement, considering FABs clients include 8 of the top 10 Pharma companies in the world by turnover, their services are well regarded.

Its only a matter of time until some of the commercial contracts start landing.

Must be tempting for someone at these levels, their addressable market has grown significantly over the last year. Very cheap at the moment.

When the company guided end of May LLoyd, were they lying?? Thats what you are implying.

Dude owns 10%, about to watch his net value soar, in his sixties, feet up time.

do some research in one sentence and then no news and sp drifting down in the other....... if youve done some research and you are confident in the company and the direction of travel ( and for that the sign posts are huge) then why would a small delay in news and a drift in shareprice be critical. octp waited two months extra for their approval, it still came, its just the civil service of this country. fca didnt give gst a sandbox plan for ****s and giggles.

I think youre right LJ, Uk want this to happen in a regulated fashion and have given us a Sandbox Plan to help the company and the UK get there. The US news shows that this is happening and the UK wont want to be left behind as is usually the case. The Asia Pacific region is the great growth area and GST have the connections there. Be crazy for the FCA and the Government not to help GST develop its model.

Since when do companies give constant updates about every little thing? They dont.

what an utter tool, contempt for shareholders? its not in the company's gift, its down to the fca. stop being a **** everyday and have the day off.

If we get the sandbox we might start to see wider recognition with the crypto bill bringing attention to the space in the UK , also there is an aquisition to come, maybe a steady sustained rise rather than the drift. But it is utterly toxic in here and the people who engage in it are doing there invesment no favours. Discussion about the use cases and potential of the company and its ofering would be more useful to new investors.

LLoyd, this all hinges on Sandbox admittance, what is your considered opinion on whether or not the company will get its approval. You have written plenty but not your analysis on why this is unlikely.

It was a good interview and Clarissa is clearly appreciative of the investor's patience.The subtle hints that there are iminenet developments with the other drug compounds is exciting as is the clear implication that once the phase 1 trial is over OCTP can go to phase two for both Chemotherapy Neuropathy and IBS, i expect other conditions as well. Clearly the MHRA delay has hurt sentiment but these levels are a steal. Some positive trial results and big Pharma will come calling as the target markets are not niche but main stream and worth Billions and growing.

How do you know Theorist?

More big buys than sells here today.....constant news appearing on the benefits of cannabinoids for medical use, markets will be in the billions.

If so then the company would have informed the market and Clarissa would not be telling people she is expecting approval as recently as last week. I think she is someone of integrity.

What can they say? were still waiting for MHRA to do their job? Im sure the company thinks like the rest of us that the MHRA are like every state body in the UK, a failing unaccountable bunch of self servants who believe we are here to provide for them. Its approaching 120 days since the application went in. Is it an utter joke? Yes it is but its not in the company's powers do do anything and there is little else they can say.

becoming tedious waiting for this lot to do what they say takes 60 days,4th of January the application went in. Approaching double that now.

****stan one of those places where palms got to be greased, need a local to keep things running smooth, why else is she being appointed.